Alembic Pharmaceuticals informs about press release

25 Nov 2020 Evaluate

Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Tentative Approval for Testosterone Gel, 1.62% (20.25 mg/ 1.25 gm actuation). The company has enclosed a press on 25th November 2020 regarding the announcement.

The above information is a part of company’s filings submitted to BSE.





Alembic Pharma Share Price

1121.40 -7.35 (-0.65%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.